Filter
664
Filtered Results: 664
Text search:
liver
cancer
Featured
Recommendations
102
New Publications
198
Language
Document type
No document type
379
Guidelines
118
Studies & Reports
83
Manuals
34
Strategic & Response Plan
19
Fact sheets
14
Training Material
11
Brochures
3
Infographics
2
App
1
Countries / Regions
India
64
Global
39
Kenya
25
South Africa
23
Ethiopia
17
Philippines
15
Nigeria
14
Rwanda
12
Latin America and the Carribbean
12
Zambia
11
Tanzania
11
Namibia
10
Western and Central Europe
10
South–East Asia Region
9
Myanmar / Burma
8
Ghana
7
Nepal
6
Uganda
5
Germany
5
Bangladesh
5
Malawi
5
Lesotho
5
Africa
5
Russia
5
Asia
4
Sierra Leone
3
Syria
3
Indonesia
3
Argentina
3
Eswatini/ Swaziland
3
Ukraine
3
Botswana
3
Middle East and North Africa
3
Eastern Europe
3
Moldova
3
Senegal
2
USA
2
Cameroon
2
Zimbabwe
2
Haiti
2
Mozambique
2
East and Southern Africa
2
West and Central Africa
2
Eastern Europe and Central Asia
2
Liberia
1
Saudi Arabia
1
Somalia
1
Pakistan
1
Iraq
1
Jordan
1
Afghanistan
1
Lebanon
1
Turkey
1
Egypt
1
Cambodia
1
Gambia
1
China
1
Sudan
1
Peru
1
Brazil
1
Libya
1
Mexico
1
Yemen
1
Western Pacific Region
1
Bhutan
1
Palestine
1
Djibouti
1
Laos
1
Qatar
1
Iran
1
Kazakhstan
1
Vietnam
1
North America
1
Jamaica
1
Japan
1
Azerbaijan
1
Latvia
1
Authors & Publishers
Publication Years
Category
Countries
285
Clinical Guidelines
93
Public Health
53
Women & Child Health
34
Capacity Building
11
Key Resources
8
Pharmacy & Technologies
5
Toolboxes
HIV
56
Mental Health
50
NCDs
32
COVID-19
30
TB
28
Pharmacy
25
Refugee
21
Caregiver
18
Planetary Health
16
NTDs
14
Global Health Education
10
AMR
9
Rapid Response
7
Conflict
5
Specific Hazards
5
Ebola
4
Disability
3
Natural Hazards
3
Cholera
2
Health Financing Toolbox
2
A Health Handbook for Women with Disabilities > Chapter 8
Effective implementation of WHO PEN, combined with other very cost effective population-wide interventions, will help even resource constrained settings to attain the global voluntary targets related to reduction of premature mortality and preventionof heart attacks and strokes.
Direct acting antivirals (DAAs) have revolutionized treatment for hepatitis C. Combi-
nations of DAAs can cure infection with HCV in 12 weeks, are highly effective and
have limited side-effects. Affordability of DAAs has improved significantly, but access remains lim-
i...
As the Americas undergo profound demographic change and there are more persons aged 65 years or older than children younger than 5 years, it is crucial to recognize that national immunization programs must be redesigned to ensure comprehensive protection for individuals across the lifespan. By adopt...
This global status report on prevention and control of NCDs (2014), is framed around the nine voluntary global targets. The report provides data on the current situation, identifying bottlenecks as well as opportunities and priority actions for attaining the targets. The 2010 baseline estimates on N...
Noncommunicable diseases (NCDs) are the principal cause of morbidity, disability and premature mortality in Azerbaijan. The most effective way to reduce the NCD burden is to prevent NCD development, by addressing thebehavioural risk factors underlying NCDs at the population and individual leve...
Updated Guidelines
The harmful use of alcohol causes approximately 3 million deaths every year and the overall burden of disease and injuries attributable to alcohol consumption remains unacceptably high. The pace of development and implementation of alcohol policies has been uneven in WHO regions, and resources and c...
Alcohol consumption is deeply embedded in the social landscape of many societies. Several major factors have an impact on levels and patterns of alcohol consumption in populations – such as historical trends in alcohol consumption, the availability of alcohol, culture, economic status and trends i...
A practical manual - The book provides step by step guidance
to the process of rational prescribing, together with many illustrative examples. It teaches skills that are necessary throughout a clinical career.
5th edition.
The objectives of these WHO guidelines are to provide updated evidence- based recommendations for the treatment of persons with hepatitis C infection using, where possible, all DAA-only combinations. The guidelines also provide recommendations on the preferred regimens based on a patient’s HCV gen...
